XMD17-109
XMD17-109 is a novel, specific ERK-5 inhibitor, which inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM, and has an EC50 of 4.2 μM.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62215R-BF405-01 20 µL
Adenosine deaminase Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details bsm-62215R-BF405-02 100 µL
Adenosine deaminase Recombinant Antibody, AbBy Fluor™ 405 Conjugated
Sign In for Pricing
View Details 